Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol

The pharmacological treatment for stable COPD is based on the use of inhaled bronchodilators (long-acting muscarinic receptor antagonists and long-acting beta-2 adrenoceptor agonists) and inhaled corticosteroids. The use of triple inhaled therapy is recommended to selected patients with COPD. Among...

Descripción completa

Detalles Bibliográficos
Autores principales: Molino, Antonio, Calabrese, Giovanna, Maniscalco, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997126/
https://www.ncbi.nlm.nih.gov/pubmed/29922045
http://dx.doi.org/10.2147/PPA.S152179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997126/
https://www.ncbi.nlm.nih.gov/pubmed/29922045
http://dx.doi.org/10.2147/PPA.S152179

Ejemplares similares